POWAY, Calif., Sept. 8 /PRNewswire/ -- NEXUS Biosystems, Inc., a leading innovator and worldwide provider of automated sample management systems, today announced the completion of the acquisition of REMP AG of Switzerland, a wholly-owned subsidiary of the Tecan Group.
NEXUS announced on July 15, 2010 that it would acquire Tecan's worldwide REMP Sample Management business. REMP is a leading global provider of sample management systems and related sample management devices, instruments, consumables and software. With this acquisition, NEXUS will be adding to its current operations in the United States and Germany the REMP operations in Switzerland, Germany, Japan and the United States. REMP provides additional R&D, manufacturing, sales and customer support operations in Switzerland and direct sales and customer support in Kawasaki, Japan.
John Lillig‚ CEO of NEXUS Biosystems, commented: "Both REMP and NEXUS have been strong innovators and leaders in the growing global automated chemical and biological sample management markets. Together, with our new REMP colleagues, we look forward to continuing to provide leading sample management solutions to our biopharmaceutical, biorepository, diagnostic, forensic, agrochemical and genomic research customers around the world. The combined NEXUS-REMP resources will strengthen our overall capabilities with expanded first-class service and support for our worldwide customers and a growing pipeline of new product offerings for the growing global sample management community."
About NEXUS Biosystems:
NEXUS Biosystems (www.nexusbio.com) is a leading innovator and worldwide provider of enabling technologies and automated sample management systems for pharmaceutical, biotech, biorepository, agrochemical and related research institutions worldwide. NEXUS products include the NEXUS Universal Store family of a